Specifically, in the tumor from patient #7, genes involved in T cell activation and signaling such as PTPRC (which encodes CD45), LCP2, FYB, CD3E, and LCK, and in genes involved in immune response and interferon signaling such as STAT1, OAS2, and HLA were downregulated. This evidence concerns the gene PTPRC and neoplasm.